Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSS2000058	依帕伐单抗注射液	emapalumab	Injection	Biological Products(3.1)	Import Drug Application	2020-12-10	苏庇医药（广州）有限公司	Supi Pharmaceutical (Guangzhou) Co Ltd;Patheon Italia SpA;Swedish Orphan Biovitrum AB	In Review	2020-12-09	view
JXSS2000060	依帕伐单抗注射液	emapalumab	Injection	Biological Products(3.1)	Import Drug Application	2020-12-10	苏庇医药（广州）有限公司	Supi Pharmaceutical (Guangzhou) Co Ltd;Patheon Italia SpA;Swedish Orphan Biovitrum AB	In Review	2020-12-09	view
JXSS2000059	依帕伐单抗注射液	emapalumab	Injection	Biological Products(3.1)	Import Drug Application	2020-12-10	苏庇医药（广州）有限公司	Supi Pharmaceutical (Guangzhou) Co Ltd;Patheon Italia SpA;Swedish Orphan Biovitrum AB	In Review	2020-12-09	view